Bruce Mackle | Managing Director, LifeSci Advisors |
Manoussos Perros | President and CEO |
Mike Gutch | CFO and Chief Business Officer |
David Altarac | Chief Medical Officer |
Matthew Luchini | BMO Capital Markets |
Ed Arce | H.C. Wainwright & Co. |
Good morning, ladies and gentlemen, and welcome to the Entasis Therapeutics' Second Quarter Results Conference Call. Currently, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time.
As a reminder, this conference call is being recorded. I will now turn the call over to Bruce Mackle, Managing Director with LifeSci Advisors.